Bristol Investment Group Announces Investment Opinion on Discovery Laboratories, Inc.Business Editors NOTE TO EDITORS: The following is an investment opinion issued by Bristol Investment Group NEW YORK--(BUSINESS WIRE)--Aug. 7, 2002 Bristol Investment Group Bristol Investment Group Initiates Coverage of Discovery Laboratories, Inc. (DSCO) with a Speculative Buy Recommendation Bristol Investment Group, the New York-based investment banking firm, has initiated coverage of Discovery Laboratories, Inc. (NasdaqSC: DSCO) with a "Speculative Buy" recommendation. Bristol set a twelve-month target price of $5. About Discovery Laboratories: Discovery Laboratories is a specialty pharmaceutical company leveraging its platform technology in humanized lung surfactants to develop potential novel respiratory therapies and pulmonary drug delivery products. Discovery's technology is being developed initially for critical care patients with life threatening respiratory disorders where there are few or no approved therapies available. Surfaxin, Discovery's lead product, is currently in two pivotal Phase 3 multi-national trials for Respiratory Distress Syndrome respiratory distress syndrome or hyaline membrane disease Common complication in newborns, especially after premature birth. Symptoms include very laboured breathing, bluish skin tinge, and low blood oxygen levels. (RDS (1) (Remote Data Services) A set of programming interfaces from Microsoft that enables users to update data on the Internet or intranets from their ActiveX-enabled browser. ) in premature infants, a Phase 3 clinical trial phase 3 clinical trial Phase 3 study. See Phase study. for Meconium Aspiration (MAS) in full-term infants, and a Phase 2 clinical trial phase 2 clinical trial Phase 2 study. See Phase study. for Acute Respiratory Distress Syndrome acute respiratory distress syndrome n. See adult respiratory distress syndrome. (ARDS Ards District (pop., 2001: 73,244), Northern Ireland. Formerly part of County Down, Ards was established as a district in 1973. Much of its land is devoted to crops and pasture. Newtownards, settled c. 1608 by Scots, is its administrative seat and manufacturing centre. ) in adults. About Bristol Investment Group Bristol Investment Group is a private investment firm focused on investing in and raising capital for high growth and special situation public and private companies, in industries such as healthcare, information technology, communications semiconductors. Bristol also provides M&A services and institutionally focused equity research. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion